gdwl_ex321.htm

EX-32.1 4 gdwl_ex321.htm CERTIFICATION gdwl_ex321.htm

EXHIBIT 32.1

SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

OF GOLDENWELL BIOTECH, INC.

In connection with the accompanying Quarterly Report on Form 10-Q of Goldenwell Biotech, Inc. for the quarter ended March 31, 2022, the undersigned, Shuang Liu, Chief Executive Officer of Goldenwell Biotech, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

such Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

the information contained in such Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 fairly presents, in all material respects, the financial condition and results of operations of Goldenwell Biotech, Inc.

Date: May 18, 2022

/s/ Shuang Liu

Name: Shuang Liu

Title: Chief Executive Officer

(principal executive officer)

(1)	such Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)	the information contained in such Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 fairly presents, in all material respects, the financial condition and results of operations of Goldenwell Biotech, Inc.

Date: May 18, 2022	/s/ Shuang Liu
	Name: Shuang Liu
	Title: Chief Executive Officer
	(principal executive officer)